📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 20:58
136 analysed today
FollowTelegram
136
Today
149,537
All-time analysed
42,893
Positive
6,653
Negative
91,318
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Skybiotech Healthcare Approves Q1 Results; Reports Revenue of ₹0.49 Cr and Net Loss of ₹0.57 Cr
Skybiotech Healthcare Limited approved its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, at its board meeting on August 14, 2026. For the quarter, the company posted a revenue of ₹0.49 crore alongside an operating loss of ₹0.52 crore. Net loss for the period stood at ₹0.57 crore with a basic EPS of -₹2.56. The statutory auditor's limited review report was also taken on record without explicit modifications mentioned in the outcome filing.
Confidence: HIGH
What changedFormal board approval and release of unaudited financial results for the quarter ended June 30, 2026.
Why it mattersDemonstrates continued operating losses (₹0.52 crore) on very modest quarterly sales of ₹0.49 crore relative to a net worth of ₹12 crore.
Quarterly Revenue: ₹0.4931 crQuarterly Net Loss: -₹0.5736 crQuarterly EPS: -₹2.56Meeting Date: 14/08/2026
📅 Short termPerformance reflects ongoing operational challenges with no immediate signs of a revenue ramp-up.
📈 Long termLimited unless the company achieves scale and turns operating profits positive.
⚠ Risk flags
- Persistent operating and net losses
- Extremely low revenue base
Key Highlights
Board approved Un-Audited Financial Results for the quarter ended June 30, 2026 on August 14, 2026
Reported quarterly revenue of ₹0.4931 crore for the period
Recorded an operating loss of ₹0.5246 crore and net loss of ₹0.5736 crore (EPS of -₹2.56)
Board meeting commenced at 05:00 PM and concluded at 08:45 PM on August 14, 2026
👀 What to Watch
Monitor upcoming quarterly updates to see if the company can expand its revenue base and reverse operating losses.
